Invesco Ltd. Orgenesis Inc. Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 17, 2021
SELL
$4.19 - $5.88 $62,363 - $87,517
-14,884 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$4.77 - $8.08 $2,847 - $4,823
597 Added 4.18%
14,884 $85,000
Q4 2020

Feb 16, 2021
BUY
$4.4 - $5.63 $62,862 - $80,435
14,287 New
14,287 $64,000

Others Institutions Holding ORGS

# of Institutions
3
Shares Held
146K
Call Options Held
0
Put Options Held
0
View Full List

About Orgenesis Inc.

ORGS Quotes by TradingView
  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $27.8M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email